The European Biotech News Website
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
|
At the present time, no one knows exactly what will happen once the UK leaves the EU, and regulatory affairs stand at the front line in interpreting what change Brexit will bring to the clinical trial process in Europe. Dr. Martine Dehlinger-Kremer of SynteractHCR shared what she expects.